A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody

NCT07445815 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Rabies (Healthy Volunteers)

Interventions

DRUG: Recombinant Human Rabies Virus Monoclonal Antibody Injection
DRUG: Human Rabies Immunoglobulin (HRIG)
DRUG: Placebo
BIOLOGICAL: Rabies Vaccine

Sponsor

Lanzhou Institute of Biological Products Co., Ltd